Kraus W, Haanes-Fritz E, Cleary P P, Seyer J M, Dale J B, Beachey E H
Veterans Administration Medical Center, Memphis, TN 38104.
J Immunol. 1987 Nov 1;139(9):3084-90.
The NH2-terminal sequence of type 1 M protein was determined by automated Edman degradation of purified polypeptide fragments extracted from whole streptococci by limited digestion with pepsin. Three polypeptide fragments were purified by slab gel electrophoresis on sodium dodecyl sulfate (SDS) polyacrylamide followed by electroelution. The purified fragments migrated as 28-, 25-, and 23.5-kDa fragments, respectively. Each of the fragments inhibited opsonization of a diluted antiserum prepared in rabbits by immunization with whole type 1 streptococci. The amino-terminal sequences of the peptide fragments were confirmed by comparison with the primary structure predicted from the nucleotide sequence of the type 1 M protein structural gene. The 28-kDa fragment contained the NH2-terminal asparagine residue of the processed type 1 M protein, whereas the NH2-terminal sequences of the 25- and 23.5-kDa peptides began at residues 27 and 36, respectively. A seven-residue periodicity with respect to polar and nonpolar residues was observed beginning at residue 22 and, therefore, the secondary structural potential of type 1 M protein is similar to that reported for other M proteins. In contrast to the other M proteins, however, identical repeats were rare, the longest sequence identity consisting of a three-amino acid acid sequence Lys-Asp-Leu at positions 30-32 repeated once at positions 65-67. A 23-residue synthetic peptide of the amino-terminus of the type 1 M protein evoked opsonic antibodies against type 1 streptococci. These results indicate that the NH2-terminal region of type 1 M protein retains the secondary structural characteristics of other M serotypes. Moreover, it contains epitopes that evoke protective immune responses. Our studies may have bearing in the development of safe and effective vaccines against group A streptococcal infections.
通过用胃蛋白酶有限消化从完整链球菌中提取的纯化多肽片段,采用自动埃德曼降解法测定了1型M蛋白的氨基末端序列。通过在十二烷基硫酸钠(SDS)聚丙烯酰胺上进行平板凝胶电泳,随后进行电洗脱,纯化了三个多肽片段。纯化后的片段分别以28 kDa、25 kDa和23.5 kDa的片段形式迁移。每个片段都抑制了用完整1型链球菌免疫制备的兔稀释抗血清的调理作用。通过与从1型M蛋白结构基因的核苷酸序列预测的一级结构进行比较,证实了肽片段的氨基末端序列。28 kDa的片段包含加工后的1型M蛋白的氨基末端天冬酰胺残基,而25 kDa和23.5 kDa肽的氨基末端序列分别从第27和36位残基开始。从第22位残基开始观察到极性和非极性残基的七残基周期性,因此,1型M蛋白的二级结构潜力与其他M蛋白报道的相似。然而,与其他M蛋白不同的是,相同的重复序列很少见,最长的序列同一性由30 - 32位的三氨基酸序列Lys - Asp - Leu在65 - 67位重复一次组成。1型M蛋白氨基末端的一个23残基合成肽引发了针对1型链球菌的调理抗体。这些结果表明,1型M蛋白的氨基末端区域保留了其他M血清型的二级结构特征。此外,它包含能引发保护性免疫反应的表位。我们的研究可能对开发针对A组链球菌感染的安全有效疫苗有帮助。